ClinicalTrials.govpublic full text
Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
carcinoma, non-small-cell lung, non-small cell lung cancer, neoplasms, pulmonary, lung cancer, cancer of the lung, stage iiib non-small cell lung cancer, iv non-small cell lung cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007865
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.